These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 24431303)

  • 1. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
    Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
    Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome.
    Lim AM; Do H; Young RJ; Wong SQ; Angel C; Collins M; Takano EA; Corry J; Wiesenfeld D; Kleid S; Sigston E; Lyons B; Fox SB; Rischin D; Dobrovic A; Solomon B
    Int J Cancer; 2014 Aug; 135(4):887-95. PubMed ID: 24436120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
    Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral tongue squamous cell carcinoma in never-smokers: analysis of clinicopathologic characteristics and survival.
    Durr ML; van Zante A; Li D; Kezirian EJ; Wang SJ
    Otolaryngol Head Neck Surg; 2013 Jul; 149(1):89-96. PubMed ID: 23533221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin.
    Küsters-Vandevelde HV; Van Leeuwen A; Verdijk MA; de Koning MN; Quint WG; Melchers WJ; Ligtenberg MJ; Blokx WA
    Int J Cancer; 2010 May; 126(9):2123-32. PubMed ID: 19739123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue.
    Harris SL; Thorne LB; Seaman WT; Hayes DN; Couch ME; Kimple RJ
    Head Neck; 2011 Nov; 33(11):1622-7. PubMed ID: 21990227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL
    Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous deletions of UGT2B17 modifies effects of smoking on TP53-mutations and relapse of head and neck carcinoma.
    Mafune A; Hama T; Suda T; Suzuki Y; Ikegami M; Sakanashi C; Imai S; Nakashima A; Yokoo T; Wada K; Kojima H; Urashima M
    BMC Cancer; 2015 Mar; 15():205. PubMed ID: 25886176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer.
    Tan C; Xu HY; Zhang CY; Zhang H; Chen CM; Zhang WM; Sun XY; Jin YT
    Arch Med Res; 2011 Nov; 42(8):669-76. PubMed ID: 22154617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS; Tsai YS; Chow NH
    Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes.
    Alsofyani AA; Dallol A; Farraj SA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Al-Khayyat SS; Alkhatabi H; Elaimi A; Buhmeida A; Johargy AK; Abuzenadah AM; Azhar EI; Al-Qahtani MH
    Cancer Biomark; 2020; 28(2):213-220. PubMed ID: 32250288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas.
    Högmo A; Börresen-Dale AL; Blegen H; Lindholm J; Kuylenstierna R; Auer G; Munck-Wikland E
    Anticancer Res; 1999; 19(4C):3433-8. PubMed ID: 10629631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
    Bova RJ; Quinn DI; Nankervis JS; Cole IE; Sheridan BF; Jensen MJ; Morgan GJ; Hughes CJ; Sutherland RL
    Clin Cancer Res; 1999 Oct; 5(10):2810-9. PubMed ID: 10537346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathologic factors of prognostic significance in penile squamous cell carcinoma in a North American population.
    Bethune G; Campbell J; Rocker A; Bell D; Rendon R; Merrimen J
    Urology; 2012 May; 79(5):1092-7. PubMed ID: 22386252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M; Peraud A; Leroch B; Kreth FW
    Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostication of vulvar cancer based on p14ARF status: molecular assessment of transcript and protein.
    Lavorato-Rocha AM; de Melo Maia B; Rodrigues IS; Stiepcich MM; Baiocchi G; da Silva Cestari FM; Carvalho KC; Soares FA; Rocha RM
    Ann Surg Oncol; 2013 Jan; 20(1):31-9. PubMed ID: 22878614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
    Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
    Makino T; Yamasaki M; Miyata H; Yoshioka S; Takiguchi S; Fujiwara Y; Nakajima K; Nishida T; Mori M; Doki Y
    Ann Surg Oncol; 2010 Mar; 17(3):804-11. PubMed ID: 19885698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma initially occurring on the tongue dorsum: a case series report with molecular analysis.
    Ono S; Hirose K; Sukegawa S; Obata K; Masui M; Hasegawa K; Fujimura A; Shimada K; Nakamura S; Teramoto A; Hori Y; Morii E; Motooka D; Igawa T; Tanaka T; Nagatsuka H; Toyosawa S; Yamamoto H
    Diagn Pathol; 2024 Apr; 19(1):63. PubMed ID: 38650013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted next-generation sequencing of TP53 in oral tongue carcinoma from non-smokers.
    Faden DL; Arron ST; Heaton CM; DeRisi J; South AP; Wang SJ
    J Otolaryngol Head Neck Surg; 2016 Sep; 45(1):47. PubMed ID: 27640185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.